AKT1 and neuroblastoma: The modulation of PI3K seems relevant also for brain tumor onset, as demonstrated by the increased expression of CDC42 through the PI3K/AKT/N-myc signaling pathway, which correlates with undifferentiated childhood neuroblastoma (Lee et al., 2014).